Lung Cancer Treatment

 

Get the Flash Player to see this content.

 

What is Cyberknife VSI and How Can it Help Treat Lung Cancer?

The Cyberknife VSI is a robotic radiosurgery system that can deliver extremely precise doses of radiation to lung & pulmonary tumors, while sparing healthy surrounding tissue. Cyberknife can even treat inoperable tumors and offers the most sophisticated non-invasive radiation treatment available, as other radiosurgery systems cannot treat tumors with the same level of accuracy and are more invasive. Treatment of lung cancer depends on the type and stage of cancer, and typically involves a combination of surgery, chemotherapy and radiation treatments. Cyberknife can be used in conjunction with surgery and chemotherapy, and offers many advantages over traditional radiation treatments.

The challenge that doctors face with radiation therapy options for lung tumors is that those tumors move as the patient breathes. Cyberknife offers the accuracy required to safely treat lung tumors, even those close to critical structures, while controlling and adjusting to patient breathing and tumor movement. The advantage that Colorado Cyberknife offers patients is that we are one of a few facilities in the world to offer the latest non-invasive radiation treatment, with the next-generation Cyberknife VSI unit, which brings revolutionary benefits. We also boast the region’s leading radiosurgery doctors.

Benefits of Cyberknife VSI Treatment for Lung & Pulmonary Tumors

 

Non-Invasive & Reduced Treatment Time

Cyberknife’s latest technology, Lung Optimized Treatment, is truly non-invasive compared to other radiation options, as it is the first system capable of delivering treatment without the need for invasive radiographic marker implantation. Cyberknife’s treatment is an out-patient procedure, completed in as little as five treatments. No anesthesia is required and the treatment process is painless and comfortable.
Cyberknife can treat patients who:
– Prefer a non-invasive approach.
– Cannot tolerate surgery due to cardiac problems.
– Have inoperable tumors.
– Need radiation therapy after surgery.

Targeting tumors from virtually any angle1 Lung Cancer Treatment

 

Target the Tumor, Not Healthy Tissue

What differentiates Cyberknife from other radiation options and radiosurgery systems, is its unique ability to precisely target a tumor, with sub-millimeter accuracy, while sparing healthy tissue and anatomy. Cyberknife’s Lung Optimized Treatment, recently approved by the FDA , allows the clinician to provide extremely precise and individualized treatment.
Cyberknife’s precision involves the following:
– Pre-Imaging, such as a CT, MRI or Pet Scan, that locates the               tumor’s size & shape,as well as any nearby structures.
– Real-time imaging and synchronization to patient breathing        and tumor movement.
– Simulation models that uncover the optimal treatment approach.
– Delivery of radiation beams from virtually any angle.

Cyberknife Destroying Tumors1 Lung Cancer Treatment

 

Little to No Recovery Time or Side Effects

Cumulative radiation exposure is significantly less with Cyberknife compared to other radiation treatment options, resulting in minimal to no side effects or recovery time. Patients may have mild nausea or fatigue after a treatment, which should resolve within a week or two after treatment. Cyberknife’s precision allows for higher radiation dosing per treatment, which also reduces the total number of treatment sessions significantly compared to other radiation therapy options, making it easy to return to work or normal activities.

Couple Running Lung Cancer Treatment

.

Cyberknife Treatment Studies for Lung Cancer Patients

Radical CyberKnife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. Georgetown researchers treated 20 patients with inoperable clinical stage I NSCLC with the CyberKnife System, delivering doses of 42-60 Gy in three equal fractions. At a median follow-up of 25 months for surviving patients, Kaplan-Meier overall survival at two years was 87%.

Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Researchers from Rotterdam, The Netherlands, reported on quality of life of 39 lung cancer patients in the first year after treatment with the CyberKnife System. In addition to a high tumor control rate and acceptable overall survival, the researchers observed no deterioration in global health status and respiratory symptoms, and a significant improvement in emotional functioning.

.

What Are the Indications for Using Cyberknife on Lung & Pulmonary Tumors?

  • Localized, Solid Mass Tumors.
  • Medically Inoperable Tumors.
  • Unresectable and Marginally Resectable Tumors
  • Tumors Adjacent to Critical Structures.
  • Tumors Treated with Radiotherapy Previously.
  • Tumors with High Risk of Recurrence.
  • Radioresistant Tumors.
  • Tumors that Cause Pain.
  • Tumors that Move.
  • Adjunct Therapy to Other Treatments to Maximize Success.

 

Compassionate Care Travel Assistance Program:

Offered Exclusively By Colorado CyberKnife.

We are setting the standard for compassionate care.
Colorado CyberKnife will cover air travel and lodging within the cost of treatment.*

Our goal is to help patients focus on their education and clinical decision making with their Physician Specialists by alleviating the anxiety insurance and other financial factors can add to this trying time.

Please inquire about our Compassionate Care Travel Assistance Program.

*All patients with governmental insurance plans such as Medicare, Medicaid, TriCare, VA, DOD, etc excluded by law.

 

 

contact colorado cyberknife Lung Cancer Treatment
.
.
.